159 related articles for article (PubMed ID: 23880016)
1. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
[TBL] [Abstract][Full Text] [Related]
2. Questionnaires for Neurogenic Lower Urinary Tract Dysfunction.
Welk B
Urol Clin North Am; 2024 May; 51(2):233-238. PubMed ID: 38609195
[TBL] [Abstract][Full Text] [Related]
3. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
[TBL] [Abstract][Full Text] [Related]
4. [Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].
Domurath B; Flachenecker P; Henze T; Feneberg W; Brandt A; Kurze I; Kirschner-Hermanns R; Kaufmann A; Bremer J; Vonthien M; Ratering K; Schäfer C; Vance WN; Schmidt P
Nervenarzt; 2021 Apr; 92(4):349-358. PubMed ID: 33399923
[TBL] [Abstract][Full Text] [Related]
5. Urinary Symptoms Among People With Neurogenic Lower Urinary Tract Dysfunction (NLUTD) Vary by Bladder Management.
Tractenberg RE; Groah SL; Frost JK; Yumoto F; Rounds AK; Ljungberg IH
Top Spinal Cord Inj Rehabil; 2023; 29(3):31-43. PubMed ID: 38076287
[TBL] [Abstract][Full Text] [Related]
6. Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
Sammer U; Walter M; Knüpfer SC; Mehnert U; Bode-Lesniewska B; Kessler TM
PLoS One; 2015; 10(10):e0140970. PubMed ID: 26513149
[TBL] [Abstract][Full Text] [Related]
7. A Framework for Addressing Health Disparities in Adult Neurogenic Lower Urinary Tract Dysfunction-Systematic Review and Neurogenic Bladder Research Group Recommendations.
Cox S; Dodo-Williams T; Branche B; García-Peñaloza N; Lucas M; Santiago-Lastra Y;
Urol Clin North Am; 2024 May; 51(2):285-295. PubMed ID: 38609200
[TBL] [Abstract][Full Text] [Related]
8. The Ideal Neurogenic Bladder Management Team.
Hogue LL; Kennelly M
Urol Clin North Am; 2024 May; 51(2):297-303. PubMed ID: 38609201
[TBL] [Abstract][Full Text] [Related]
9. Neurogenic Lower Urinary Tract Dysfunction.
Wiener JS; Chaudhry R
Urol Clin North Am; 2023 Aug; 50(3):415-432. PubMed ID: 37385704
[TBL] [Abstract][Full Text] [Related]
10. Re: What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel.
Tyagi P; Chancellor M
Eur Urol; 2024 Apr; 85(4):394. PubMed ID: 38278662
[No Abstract] [Full Text] [Related]
11. Disruption of specific white matter tracts is associated with neurogenic lower urinary tract dysfunction in women with multiple sclerosis.
Choksi D; Schott B; Tran K; Jang R; Hasan KM; Lincoln JA; Jalali A; Karmonik C; Salazar B; Khavari R
Neurourol Urodyn; 2023 Jan; 42(1):239-248. PubMed ID: 36321777
[TBL] [Abstract][Full Text] [Related]
12. Voiding Phase Dysfunction in Multiple Sclerosis: Contemporary Review of Terminology, Diagnosis, Management, and Future Directions.
Ingram CF; Lincoln JA; Khavari R
Urol Clin North Am; 2024 May; 51(2):177-185. PubMed ID: 38609190
[TBL] [Abstract][Full Text] [Related]
13. [Neuro-urological diagnostics and treatment of non-traumatic/degenerative neurogenic lower urinary tract dysfunction exemplified by multiple sclerosis].
Kurze I; Jaekel AK
Aktuelle Urol; 2024 Apr; ():. PubMed ID: 38653466
[TBL] [Abstract][Full Text] [Related]
14. [Bladder Dysfunction and Neurology: How to Assess Neurogenic Bladder Dysfunction?].
Sakakibara R; Uchiyama T; Yamamoto T; Kanda T; Hattori T
Brain Nerve; 2024 Mar; 76(3):261-271. PubMed ID: 38514107
[TBL] [Abstract][Full Text] [Related]
15. Management strategies for lower urinary tract symptoms (LUTS) among people with multiple sclerosis (MS): a qualitative study of the perspectives of people with MS and healthcare professionals.
Al Dandan HB; Galvin R; McClurg D; Coote S
HRB Open Res; 2019; 2():31. PubMed ID: 32296749
[No Abstract] [Full Text] [Related]
16. MS bladder check tool: Development and validation of a patient awareness tool to facilitate timely management of lower urinary tract dysfunction due to multiple sclerosis.
Flachenecker P; Blok B; Brichetto G; Panicker JN; Phé V; Barken KB
Mult Scler Relat Disord; 2024 Feb; 82():105353. PubMed ID: 38194894
[TBL] [Abstract][Full Text] [Related]
17. Guidelines of Guidelines: Conservative, Pharmacological, and Surgical Management for Neurogenic Lower Urinary Tract Dysfunction.
Ochoa DC; Mahoney AC; Fontaine C; Hashim H
Urol Res Pract; 2024 Mar; ():. PubMed ID: 38798010
[TBL] [Abstract][Full Text] [Related]
18. [Chinese expert consensus on clinical diagnosis and treatment of non-neurogenic lower urinary tract dysfunction in children].
Pediatric Urodynamics and Pelvic Floor Group, Department of Urology and Pediatric Surgery Branch of Chinese Medical Association
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1124-1131. PubMed ID: 38583041
[TBL] [Abstract][Full Text] [Related]
19. Etiology, presentation and management of urinary tract infections in multiple sclerosis patients: A review of the current literature.
Campetella M; Filomena GB; Marino F; Fantasia F; Russo P; Gavi F; Rossi F; Gandi C; Ragonese M; Foschi N; Totaro A; Sacco E; Racioppi M; Bientinesi R
Urologia; 2024 May; 91(2):384-393. PubMed ID: 38279809
[TBL] [Abstract][Full Text] [Related]
20. A Primer for Primary Care Physicians Managing Neurogenic Bladder Patients.
Atiemo HO; Stoffel JT
Urol Clin North Am; 2024 May; 51(2):305-311. PubMed ID: 38609202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
